Correspondence 0001213900-26-040523 from Cellyan Biotechnology Co., Ltd (HKPD)
Cellyan Biotechnology Co., Ltd
Date: April 6, 2026 · CIK: 0002007702 · Accession: 0001213900-26-040523
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294685
Letter
VIA EDGAR Division of Corporation Finance Office of Trade & Services Re: Cellyan Biotechnology Co., Ltd Registration Statement on Form F-1 Filed March 27, 2026 File No. 333-294685
Dear Ms. Beukenkamp:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Cellyan Biotechnology Co., Ltd hereby requests acceleration of effectiveness of the above referenced Registration Statement on Form F-1 (File No. 333-294685) so that it will become effective at 5:00 p.m. ET on Wednesday, April 8, 2026, or as soon as thereafter practicable.
Very truly yours,
/s/ Chenyu Liang
Show Raw Text
CORRESP 1 filename1.htm CELLYAN BIOTECHNOLOGY CO., LTD Room B1, 5/F., Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon Hong Kong +852 2618-9289 April 6, 2026 VIA EDGAR U.S. Securities & Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, NE Washington, D.C. 20549 Attn: Kate Beukenkamp Re: Cellyan Biotechnology Co., Ltd Registration Statement on Form F-1 Filed March 27, 2026 File No. 333-294685 Dear Ms. Beukenkamp: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Cellyan Biotechnology Co., Ltd hereby requests acceleration of effectiveness of the above referenced Registration Statement on Form F-1 (File No. 333-294685) so that it will become effective at 5:00 p.m. ET on Wednesday, April 8, 2026, or as soon as thereafter practicable. Very truly yours, /s/ Chenyu Liang Chenyu Liang Chief Executive Officer and Director cc: McLaughlin & Stern, LLP